David Greenspan's Slate Path Capital is Buying Coinbase, Stitch Fix, and More
In this article, we discuss the top stocks recently acquired by David Greenspan's Slate Path Capital according to analysts.
Founded in Q2 of 2012, Slate Path Capital is a New York-based long/short equity hedge fund manager focused on achieving long-term capital growth through a rigorous, research-driven approach to security selection.
David Greenspan, founder and president of Slate Path Capital, launched the firm following his tenure as partner and managing director at Blue Ridge Capital in New York. He joined Blue Ridge in 2000, concurrent with earning his MBA from Columbia Business School. Before Columbia, Mr. Greenspan worked as a CPA and consultant at Price Waterhouse in Washington, DC. He holds an undergraduate degree in business administration from George Mason University, awarded in 1993. Mr. Greenspan is actively involved with Columbia Business School, serving on its Board and as an adjunct professor teaching Advanced Investment Research. He also sits on the advisory board of the School’s Heilbrunn Center for Graham & Dodd Investing.
Slate Path Capital manages assets for 6 clients with discretionary assets under management (AUM) totaling $6,880,570,797 (Form ADV from 2024-03-29). Their latest 13F filing for Q1 2024 reported $5,044,922,767 in managed 13F securities, with a top 10 holdings concentration of 47.44%. The firm's largest holding is Teva Pharmaceutical Industries Ltd, ADR, with 26,896,184 shares held.
